PetVivo Holdings Inc
Josh Wilhelm is an accomplished professional in the fields of research and development, quality assurance, and clinical studies, currently serving as Vice President of R&D and Clinical Studies and Director of Manufacturing at PetVivo Holdings Inc since September 2021. Additionally, Wilhelm is the owner of Subzero Consulting LLC, providing expert guidance in cGMP manufacturing and quality assurance for biologically-based therapeutics and medical devices. Previous roles include Assistant Women's Golf Coach at Carleton College, Senior Study Director at WuXi AppTec, and Director of Islet Manufacturing and R&D at the Schulze Diabetes Institute, where significant contributions were made in islet cell therapies. Other experience encompasses positions at Gel-Del Technologies, Medtronic, and the University of Minnesota, complemented by a Master's in Biomedical Engineering and a Bachelor's in Biology.
PetVivo Holdings Inc
PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.